Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Recruiting 2Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Mesothelioma, Malignant 13Retinoblastoma 9Mesothelioma 9Solid Tumor 7Sarcoma 6Pancreatic Neoplasms 6Lung Neoplasms 6Unspecified Childhood Solid Tumor, Protocol Specific 5Unspecified Adult Solid Tumor, Protocol Specific 5Solid Tumors 5Carcinoma, Non-Small-Cell Lung 5Ovarian Neoplasms 4Wilms Tumor 3Solid Tumor, Adult 3Neuroblastoma 3Colorectal Neoplasms 3Advanced Solid Tumors 3Advanced Solid Tumor 3Thymoma 2Stomach Neoplasms 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Osteosarcoma 2Neoplasms 2Neoplasm Metastasis 2Kidney Neoplasms 2Colonic Neoplasms 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Breast Neoplasms 2

Interventions

Injections 27Carboplatin 18Docetaxel 14pembrolizumab 13Paclitaxel 12Bevacizumab 10durvalumab 8Nivolumab 8Cisplatin 8Fluorouracil 7Pemetrexed 6Oxaliplatin 6Leucovorin 6trifluridine tipiracil drug combination 5toripalimab 5tislelizumab 5linifanib 5Capecitabine 5zimberelimab 4talazoparib 4olaparib 4fludarabine 4Panobinostat 4Itraconazole 4Irinotecan 4Gemcitabine 4Everolimus 4tremelimumab 3sotorasib 3sintilimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Advanced Solid Tumors × Cyclophosphamide × Other solid neoplasm × Clear all
NCT06773091 2026-04-06

NKSOLID

Shanghai NK Cell Technology Co., LTD

Phase 1 Recruiting
76 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT06556108 2026-01-20

ALPP CAR-T Cells for ALPP-Positive Advanced Solid Tumors

Xinqiao Hospital of Chongqing

Phase 1/2 Completed
5 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT05881525 2025-07-16

NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors

TCRCure Biopharma Ltd.

Phase 1 Recruiting
18 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡